녹차가루 식이가 당뇨쥐의 혈당 및 혈중 지질 농도에 미치는 영향

다국어 초록 (Multilingual Abstract)

The study examined the effects of dietary green tea powder supplementation on blood glucose, and plasma and liver lipid concentrations in diabetic rats. Twenty-five male Sprague-Dawley rats (body weight 200±5 g) were divided into two groups (diabetic and non-diabetic), which were each randomly divided into two subgroups that were fed a control and 1% green tea powder-supplemented diet. Serum and liver lipid concentrations were measured by established techniques. Low density lipoprotein-cholesterol (LDL-C) was calculated from an established equation. Body weight gain and feed efficiency ratio were lower in diabetic rats than in non-diabetic rats regardless of diet. There were no differences in weight gain in diabetic and non-diabetic rats consuming the control and green tea powder-supplemented diets. The levels of fasting plasma glucose, serum total cholesterol, triglyceride, LDL-C and atherogenic index of diabetic rats were significantly higher than that of non-diabetic rats. Conversely, the levels of high density lipoprotein-cholesterol (HDL-C) of diabetic rats was significantly lower than that of non-diabetic rats. Fasting plasma glucose, serum total cholesterol, triglyceride, LDL-C and atherogenic index were significantly lower in diabetic rats fed the green tea powder diet than in rats fed the control diet, and HDL-C was significantly higher in rats fed the green tea powder diet than in rats fed the control diet. The content of liver total cholesterol and triglyceride of diabetic rats were significantly higher than that of non-diabetic rats. Liver total cholesterol and triglyceride were significantly lower in diabetic rats fed green tea powder-supplemented diet than in rats fed the control diet. It is concluded that green tea powder supplementation positively influences blood glucose and lipid metabolism in diabetic rats. The present study, although not directly applicable to humans, may have some implications for individuals who habitually consume green tea powder.

참고문헌 (Reference)

1 Gross LS, "ncreased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment" 79 : 774-779, 2004

2 Sin MK, "effects of green tea on the serum lipid and liver tissue of cholesterol fed rats" 29 : 1255-1263, 1997

3 Bose M, "The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice" 138 : 1677-1683, 2008

4 Chang KJ, "The effects of taurine and β-alanine on blood glucose and blood lipid concentrations in insulin-treated diabetic rats" 4 : 103-110, 1999

5 Choi JW, "The effects of nicotinamide on the serum lipid composition in streptozotocin-induced diabetic rats" 20 : 306-311, 1991

6 Stensvold I, "Tea consumption, relationship to cholesterol, blood pressure, and coronary and total mortality" 21 : 546-553, 1992

7 Harbowy ME, "Tea chemistry" 16 : 415-480, 1997

8 Ikeda I, "Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats" 1127 (1127): 141-146, 1992

9 Goodman HO, "Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides" 43 : 1-9, 1990

10 Matsumoto N, "Reduction of blood glucose levels by tea catechin" 57 : 525-527, 1993

11 Nakagawa T, "Protective activity of green tea against free radicaland glucose-mediated protein damage" 50 : 2418-2422, 2002

12 Vinson JA, "Phenol antioxidant quantity and quality in foods: vegetables" 46 : 3630-3634, 1998

13 Centers for Disease Control and Prevention, "National Diabetes Surveillance System: prevalence of diabetes"

14 Kao YH, "Modulation of endocrine systems and food intake by green tea epigallocatechin gallate" 141 : 980-987, 2000

15 Steinberg D, "Modification of low-density-lipoprotein that increase its atherogenicity" 320 : 915-924, 1989

16 Tavia G, "Menopause and coronary heart disease: Framingham study" 89 : 157-161, 1978

17 Peterson S, "Major flavonoids in dry tea" 18 : 487-501, 2005

18 Halton TL, "Low-carbohydrate-diet score and risk of type 2 diabetes in women" 87 : 339-346, 2008

19 Seigo B, "In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats" 131 : 2885-2891, 2001

20 Venables MC, "Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans" 87 : 778-784, 2008

21 Kuriyama S, "Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study" 13 : 1255-1265, 2006

22 The Korean Nutrition Society, "Food Values"

23 Hooper L, "Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials" 88 : 38-50, 2008

24 Friedwald WT, "Estimation of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge" 18 : 499-502, 1972

25 Wolfram S, "Epigallocatechin gallate supplementation alleviates diabetes in rodents" 136 : 2512-2518, 2006

26 Rhee SJ, "Effects of green tea catechin on liver 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and serum lipid levels in streptozotocin-induced diabetic rats" 26 : 1187-1193, 1997

27 Ishikawa T, "Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification" 66 : 261-266, 1997

28 Janle EM, "Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats" 5 : 55-65, 2005

29 Potenza MA, "EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR" 292 : E1378-E1387, 2007

30 Song Y, "Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women" 27 : 59-65, 2004

31 Cameron-Smith D, "Dietary guar gum improves insulin sensitivity in Streptozotocin-induced diabetic rats" 127 : 359-364, 1997

32 Ebeler SE, "Dietary catechin delays tumor onset in a transgenic mouse model" 76 : 865-872, 2002

33 Villegas R. Gao YT, "Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study" 89 : 1059-1067, 2009

34 Frank J, "Dietary (+)-catechin and BHT markedly increase α-tocopherol concentrations in rats by a tocopherol-ω-hydroxylase.independent mechanism 1,2" 133 : 3195-3199, 2003

35 Holden JM, "Development of a database of critically evaluated flavonoids data: Application of USDA's data quality evaluation" 18 : 829-884, 2005

36 Odegaard AO, "Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study" 88 : 979-985, 2008

37 Centers for disease control and prevention, "Census of the population and population estimates" Centers for Disease Control and Prevention 1997

38 Adcocks C, "Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type Ⅱ collagen degradation in vitro" 132 : 341-346, 2002

39 Arts ICW, "Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: The Zutphen elderly study" 74 : 227-232, 2001

40 Feinglos MN, "Are you what you eat, or how much you eat?: The case of type 2 diabetes mellitus" 168 : 1485-1486, 2008

41 Choe WK, "Antitumor effects of green tea catechin on different cancer cells" 32 : 838-843, 1999

42 Frei B, "Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies" 133 : 3275S-3284S, 2003

43 Folch J, "A simple method for the isolation and purification of total lipids from animal tissue" 226 : 497-509, 1957

44 Crespy V, "A review of the health effects of green tea catechins in in vivo animal models1" 134 : 3431S-2440S, 2004

45 Ministry of Health and Welfare, "2007 Korean national health and nutrition examination survey" 256-, 2009